OpenBilldrug price receipt

NADAC week of 2026-10-14

TRI-SPRINTEC TABLET

FDA nonproprietary name: norgestimate and ethinyl estradiol

For 1 unit (EA)

Pharmacies pay

$0.13 filed

1 × $0.12642 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$0.40 filed

1 × $0.39518 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.1× estimated

Medicare paid 3.1× what pharmacies pay.

Part D averages every strength and form sold under “Tri-Sprintec” / “Norgestimate-Ethinyl Estradiol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.15 estimated

$0.13 + $0.02 (15%) + $5.00 fee per fill = $5.15

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TRI-SPRINTEC TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as norgestimate and ethinyl estradiol, under the trade name “Tri-Sprintec”.

FDA gives its dosage form as kit.

The labeler, the company named on the label, is Teva Pharmaceuticals USA, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00555-9018-58.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.13 for 1 unit (EA) (1 × $0.12642 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

16 other products in the NADAC file share the FDA nonproprietary name norgestimate and ethinyl estradiol with TRI-SPRINTEC TABLET.

ProductPharmacies pay per unitMedicare per unit
ESTARYLLA 0.25-0.035 MG TABLET
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.35165 per EA filed
Part D 2024 average
MILI 0.25-0.035 MG TABLET
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.3497 per EA filed
Part D 2024 average
MONO-LINYAH 28 TABLET
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.40861 per EA filed
Part D 2024 average
NORG-EE 0.18-0.215-0.25/0.035
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.41646 per EA filed
Part D 2024 average
NORG-ETHIN ESTRA 0.25-0.035 MG
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.41646 per EA filed
Part D 2024 average
SPRINTEC 28 DAY TABLET
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.3449 per EA filed
Part D 2024 average
TRI-ESTARYLLA TABLET
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.44653 per EA filed
Part D 2024 average
TRI-LINYAH TABLET
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.42225 per EA filed
Part D 2024 average
TRI-LO-ESTARYLLA TABLET
generic · kit
$0.10804 per EA filed
eff. 2026-09-23
$0.54538 per EA filed
Part D 2024 average
TRI-LO-MARZIA TABLET
generic · kit
$0.10804 per EA filed
eff. 2026-09-23
$0.46503 per EA filed
Part D 2024 average
TRI-LO-MILI TABLET
generic · kit
$0.10804 per EA filed
eff. 2026-09-23
$0.50205 per EA filed
Part D 2024 average
TRI-LO-SPRINTEC TABLET
generic · kit
$0.10804 per EA filed
eff. 2026-09-23
$0.53628 per EA filed
Part D 2024 average
TRI-MILI 28 TABLET
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.42482 per EA filed
Part D 2024 average
TRI-SPRINTEC TABLET this page
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.39518 per EA filed
Part D 2024 average
TRI-VYLIBRA 28 TABLET
generic · kit
$0.12642 per EA filed
eff. 2026-09-23
$0.29907 per EA filed
Part D 2024 average
TRI-VYLIBRA LO TABLET
generic · kit
$0.10804 per EA filed
eff. 2026-09-23
$0.33539 per EA filed
Part D 2024 average
VYLIBRA 28 TABLET
generic · kit
$0.11481 per EA filed
eff. 2026-09-23
$0.33659 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $0.40 for 1 unit (EA), at an average of $0.39518 per EA in 2024 (2024-01-01 to 2024-12-31) for “Tri-Sprintec” and “Norgestimate-Ethinyl Estradiol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 11,352 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TRI-SPRINTEC TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tri-Sprintec / Norgestimate-Ethinyl Estradiol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.